Where does Alkermes, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alkermes, Inc. ranks #10,842 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alkermes, Inc. hold?

Alkermes, Inc. holds 28 US utility patents granted between 2015 and 2024, spanning 8 technology areas.

What is Alkermes, Inc.'s Innovation Score?

Alkermes, Inc. has an Innovation Score of 47.2 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alkermes, Inc. focus on?

Alkermes, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 25 patents, ranking #782 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Alkermes, Inc.'s patent grant rate increasing or decreasing?

Alkermes, Inc.'s recent grant velocity is +15% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Alkermes, Inc.'s patents?

Alkermes, Inc.'s patents average 22.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alkermes, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Alkermes, Inc.

USPTO PatentsView assignee record - 28 granted patents across 8 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alkermes ranks #10,842 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 8 technology areas.

#10,842
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.2/100): 22.3
avg claims per patent: +15%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10842 · US Corporation #10,842 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #10,842/49,997
PHOTO-FINISH Acbel Polytech
CPC-NARROW A61P · 8 areas
INNOV-PAR 47.2/100
CLAIMS-DENSE 22.3 claims/avg
TYPE-USCORP US Corporation
VEL-UP +15% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acbel Polytech Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Alkermes’s 47.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (25%) Velocity 12.2 pts (26%) Breadth 10.0 pts (21%) Claim depth 13.4 pts (28%)

Qualcomm Incorporated · highest

85
China Academy OF… · near

47
Alkermes · this assignee

47
Optasense Holdings · near

47
Universite De… · near

47
Valeo Embrayages · near

47
3D Lighting… · lowest

7

What this shows Alkermes's Innovation Score is 47.2/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Alkermes?

Each dot is one of Alkermes’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Alkermes’s own 22.3 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Alkermes vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Alkermes's grants concentrate

Alkermes, Inc. is a focused PatentsView assignee: 8 CPC subclasses with 89.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2017. By volume, Alkermes sits between Astenjohnson, Inc. and Amphenol Commercial Products (Chengdu) Co., Ltd..

Alkermes's three-year grant acceleration

Alkermes, Inc. shows 11 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Astenjohnson

28
Aziende Chimiche…

28
Acbel Polytech

28
Action Target

28
Alltec Angewandte…

28
Amer Sports Digit…

28
Americorp Investm…

28
Amphenol Commerci…

28
Alkermes ◀

28

What this shows Alkermes holds 28 patents at rank #10,851, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alkermes

By rank, the assignees closest to #10,851 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Alkermes's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alkermes, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Alkermes ranks #782 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Universite De Bretagne Occidentale 47 Optasense Holdings Limited 47 Valeo Embrayages 47 China Academy OF Telecommunications Technology 47

Alkermes's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alkermes, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	17.9%
2016	4	14.3%
2017	1	3.6%
2018	1	3.6%
2019	2	7.1%
2020	1	3.6%
2021	3	10.7%
2022	4	14.3%
2023	2	7.1%
2024	5	17.9%

Which technologies does Alkermes, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 25

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 24

C07D - Heterocyclic Compounds 19

C07K - Peptides 9

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 3

C07C - Acyclic OR Carbocyclic Compounds 1

C12Y - Enzymes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Alkermes, Inc.'s patent record in context - here's where to go next.

Alkermes, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 89.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,842 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alkermes, Inc. against Astenjohnson, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.